Wenmin Zhuang, Xuemin Ding, Haixia Luo, Ludan Deng
{"title":"Study on miRNA-146a-5p rs2910164 polymorphism in attention deficit and hyperactive disorder occurrence and development.","authors":"Wenmin Zhuang, Xuemin Ding, Haixia Luo, Ludan Deng","doi":"10.1080/17410541.2026.2634610","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>This study investigated the role of miR-146a-5p rs2910164 polymorphism in attention deficit hyperactivity disorder (ADHD).</p><p><strong>Methods: </strong>This study included 180 ADHD children and 122 healthy individuals aged 6-12 years. The ADHD children were hospitalized for treatment while healthy individuals were recruited from a local primary school. ADHD patients received 24-week MPH administration, and treatment response was evaluated via ADHD-RS and CGI-S or CGI-I. miR-146a-5p levels were quantified by qRT-PCR. Multivariate logistic regression was employed for the independent risk factors including rs2910164 polymorphism and gender. MiR-146a-5p rs2910164 was genotyped via TaqMan Genotyping method.</p><p><strong>Results: </strong>In ADHD children, GG carriers exhibited markedly higher miR-146a-5p levels than GC/CC carriers. A similar genotype-related elevation was also observed but was less pronounced in control. The effect allele G and male subgroup were significantly associated with ADHD susceptibility. After 24-week MPH administration, GC and CC carriers showed higher odds of successful treatment than GG individuals in both ADHD-RS and CGI-I assessment. miR-146a-5p was increased in ADHD children and showed diagnostic promise.</p><p><strong>Conclusion: </strong>The rs2910164 polymorphism was related to ADHD children in the Chinese population. However, further validation in independent and larger populations is necessary to confirm this relationship and establish its generalizability.</p>","PeriodicalId":94167,"journal":{"name":"Personalized medicine","volume":" ","pages":"15-21"},"PeriodicalIF":0.0000,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Personalized medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/17410541.2026.2634610","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/3/5 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Objectives: This study investigated the role of miR-146a-5p rs2910164 polymorphism in attention deficit hyperactivity disorder (ADHD).
Methods: This study included 180 ADHD children and 122 healthy individuals aged 6-12 years. The ADHD children were hospitalized for treatment while healthy individuals were recruited from a local primary school. ADHD patients received 24-week MPH administration, and treatment response was evaluated via ADHD-RS and CGI-S or CGI-I. miR-146a-5p levels were quantified by qRT-PCR. Multivariate logistic regression was employed for the independent risk factors including rs2910164 polymorphism and gender. MiR-146a-5p rs2910164 was genotyped via TaqMan Genotyping method.
Results: In ADHD children, GG carriers exhibited markedly higher miR-146a-5p levels than GC/CC carriers. A similar genotype-related elevation was also observed but was less pronounced in control. The effect allele G and male subgroup were significantly associated with ADHD susceptibility. After 24-week MPH administration, GC and CC carriers showed higher odds of successful treatment than GG individuals in both ADHD-RS and CGI-I assessment. miR-146a-5p was increased in ADHD children and showed diagnostic promise.
Conclusion: The rs2910164 polymorphism was related to ADHD children in the Chinese population. However, further validation in independent and larger populations is necessary to confirm this relationship and establish its generalizability.